BR9509897A - Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal - Google Patents

Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal

Info

Publication number
BR9509897A
BR9509897A BR9509897A BR9509897A BR9509897A BR 9509897 A BR9509897 A BR 9509897A BR 9509897 A BR9509897 A BR 9509897A BR 9509897 A BR9509897 A BR 9509897A BR 9509897 A BR9509897 A BR 9509897A
Authority
BR
Brazil
Prior art keywords
composition
active material
biologically active
controlled release
pct
Prior art date
Application number
BR9509897A
Other languages
English (en)
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of BR9509897A publication Critical patent/BR9509897A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
BR9509897A 1994-12-09 1995-12-08 Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal BR9509897A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure

Publications (1)

Publication Number Publication Date
BR9509897A true BR9509897A (pt) 1997-12-30

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509897A BR9509897A (pt) 1994-12-09 1995-12-08 Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal

Country Status (13)

Country Link
US (1) US5906831A (pt)
EP (1) EP0790822B1 (pt)
JP (1) JP3487860B2 (pt)
AT (1) ATE213932T1 (pt)
AU (1) AU4276896A (pt)
BR (1) BR9509897A (pt)
CA (1) CA2207218C (pt)
DE (1) DE69525761T2 (pt)
ES (1) ES2170171T3 (pt)
FI (1) FI972415A (pt)
NO (1) NO972614L (pt)
SE (1) SE518619C2 (pt)
WO (1) WO1996017597A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
CA2508907A1 (en) 2001-11-08 2003-05-15 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
AU2002362039B2 (en) * 2001-12-03 2007-07-26 Soligenix, Inc Stabilized reverse micelle compositions and uses thereof
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1819297B1 (en) 2004-09-28 2015-01-14 Atrium Medical Corporation Uv cured gel and method of making
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
JP2010508897A (ja) 2006-11-06 2010-03-25 アトリウム メディカル コーポレーション コーティングされた外科用メッシュ
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
EP2712622B1 (en) * 2008-05-21 2016-07-13 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
EP3673738B1 (en) 2015-05-20 2024-02-28 Apeel Technology, Inc. Plant extract compositions and methods of preparation thereof
CN108135188B (zh) 2015-09-16 2022-08-05 阿比尔技术公司 用于分子涂层的前体化合物
EP3649860B1 (en) 2015-12-10 2023-02-01 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
WO2017132281A1 (en) 2016-01-26 2017-08-03 Apeel Technology, Inc. Method for preparing and preserving sanitized products
WO2018094269A1 (en) 2016-11-17 2018-05-24 Apeel Technology, Inc. Compositions formed from plant extracts and methods of preparation thereof
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
US11641865B2 (en) 2020-03-04 2023-05-09 Apeel Technology, Inc. Compounds and formulations for protective coatings
IL302360A (en) 2020-10-30 2023-06-01 Apeel Tech Inc Preparations and methods of their preparation
CA3198426A1 (en) * 2020-11-04 2022-05-12 Inolex Investment Corporation Biobased glyceryl heptanoate ester compositions and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
NO972614D0 (no) 1997-06-06
NO972614L (no) 1997-06-06
ATE213932T1 (de) 2002-03-15
FI972415A0 (fi) 1997-06-06
CA2207218C (en) 2002-02-12
CA2207218A1 (en) 1996-06-13
DE69525761T2 (de) 2002-10-24
JPH10510260A (ja) 1998-10-06
SE518619C2 (sv) 2002-10-29
AU4276896A (en) 1996-06-26
SE9404289L (sv) 1996-06-10
ES2170171T3 (es) 2002-08-01
WO1996017597A1 (en) 1996-06-13
EP0790822A1 (en) 1997-08-27
EP0790822B1 (en) 2002-03-06
FI972415A (fi) 1997-06-06
DE69525761D1 (de) 2002-04-11
JP3487860B2 (ja) 2004-01-19
US5906831A (en) 1999-05-25
SE9404289D0 (sv) 1994-12-09

Similar Documents

Publication Publication Date Title
BR9509897A (pt) Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal
DK0480982T3 (da) Tyndtflydende vacciner og bærere for aktive stoffer indeholdende en metaboliserbar olie
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
FI942791A (fi) Sekundaariset amiinit sokeritautia ja liikalihavuutta ehkäisevinä aineina
BR9714268A (pt) Composição de barra para limpeza de pele.
ES2101330T3 (es) Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado.
GB9116610D0 (en) Preparation of microparticles
AR007827A1 (es) 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos.
PT81856B (pt) Processo para a preparacao de ingredientes activos a base de 3-(2,2-di-halogenovinil)2,2-dimetil-ciclopropano-carboxilatos de alfa-ciano-3-fenoxibenzilo e de composicoes insecticidas que os contem
BR9609033B1 (pt) composição e emulsão para a liberação controlada de uma substáncia.
KR920702217A (ko) 말라리아 치료 조성물
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
BRPI0015939B8 (pt) sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
BR9813440A (pt) Processo para a preparação de uma composição amaciante de tecido lìquida
BR9810711A (pt) Formulação tópica de pulverização antipruriginosa, e, processo para prevenção ou tratamento de prurido em um paciente
BR0116179A (pt) Composição despejável, processo de preparação de uma composição despejável e uso da composição
BR9612355A (pt) Agentes de ligação com os receptores de ácido hialurÈnico e o uso destes.
KR920009406A (ko) 화상 치료제
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
NO894083L (no) Farmasoeytiske blandinger for behandling av adrenoleukodystrophy.
ES2130164T3 (es) Composicion farmaceutica para aplicacion topica que contiene ditranol y procedimiento de preparacion.
KR970061084A (ko) 닭의 발육을 촉진하는 방법
AR013381A1 (es) Una composicion liquida acuosa de limpieza y antibacteriana y el procedimiento para prepararla
KR880000094A (ko) 위염치료제

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law